Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. News
  7. Summary
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Press Release : FDA accepts application for -3-

07/29/2021 | 01:03am EDT

Phone: +41 61 688 8888 / e-mail: media.relations@roche.com https://www.globenewswire.com/Tracker?data=voTpyWPtVaHiMtrNEt2lX_4uJBj_w-UvOJnv0c4uiw763uQfK4rmzkQkJhax5lUGNkOn9gC2kFA5LgWP8U-VDpdNKofXwEJ70eRQ6PX56Ns1o1YfOwVHz11BImaoHdPa

 
Dr. Nicolas Dunant          Patrick Barth 
 Phone: +41 61 687 05 17     Phone: +41 61 688 44 86 
Dr. Barbara von Schnurbein  Karsten Kleine 
 Phone: +41 61 687 89 67     Phone: +41 61 682 28 31 
Nina Mählitz           Nathalie Meetz 
 Phone: +41 79 327 54 74     Phone: +41 61 687 43 05 
 
 
Roche Investor Relations 
Dr. Karl Mahler                        Jon Kaspar Bayard 
 Phone: +41 61 68-78503                 Phone: +41 61 68-83894 
 e-mail: karl.mahler@roche.com          e-mail: jon_kaspar.bayard@roche.com 
Dr. Sabine Borngräber             Dr. Bruno Eschli 
 Phone: +41 61 68-88027                 Phone: +41 61 68-75284 
 e-mail: sabine.borngraeber@roche.com   e-mail: bruno.eschli@roche.com 
Dr. Birgit Masjost                     Dr. Gerard Tobin 
 Phone: +41 61 68-84814                 Phone: +41 61 68-72942 
 e-mail: birgit.masjost@roche.com       e-mail: gerard.tobin@roche.com 
 
Investor Relations North America 
Loren Kalm 
 Phone: +1 650 225 3217 
 e-mail: kalm.loren@gene.com 
 

Attachment

   -- 29072021_MR_faricimab 
      https://ml-eu.globenewswire.com/Resource/Download/298f819a-bfa3-479e-bfbf-3cb8299a85f8 
 
 
 

(END) Dow Jones Newswires

July 29, 2021 01:03 ET (05:03 GMT)

All news about ROCHE HOLDING AG
09:17aROCHE HOLDINGS AG : Credit Suisse gives a Neutral rating
MD
08:58aROCHE : Canadian Blood Services selects Roche Diagnostics Canada as a partner of choice fo..
AQ
09/22ROCHE : Joins CG Oncology to Study Novel Immunotherapy Combination in Cancer Patients
MT
09/22ROCHE : Rolls Out Three Respiratory Tests On Cobas 6800/8800 Systems
MT
09/22PRESS RELEASE : Roche launches three respiratory -2-
DJ
09/22ROCHE : launches three respiratory test panels on cobas 6800/8800 Systems in CE markets to..
AQ
09/22PRESS RELEASE : Roche launches three respiratory test panels on cobas 6800/8800 Systems in..
DJ
09/22Roche Launches Three Respiratory Test Panels on Cobas 6800/8800 Systems in CE Markets t..
CI
09/21ROCHE : New Phase III Data Support the Benefit of Genentech's Tecentriq in Early-Stage Lun..
AQ
09/20ROCHE : Booster programme welcome but plans must be in place for boosters for all vaccinat..
AQ
More news
Analyst Recommendations on ROCHE HOLDING AG
More recommendations
Financials
Sales 2021 61 371 M 66 373 M 66 373 M
Net income 2021 14 747 M 15 949 M 15 949 M
Net cash 2021 4 289 M 4 638 M 4 638 M
P/E ratio 2021 19,9x
Yield 2021 2,74%
Capitalization 300 B 324 B 324 B
EV / Sales 2021 4,81x
EV / Sales 2022 4,65x
Nbr of Employees 101 465
Free-Float 83,5%
Chart ROCHE HOLDING AG
Duration : Period :
Roche Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROCHE HOLDING AG
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 342,60 CHF
Average target price 382,65 CHF
Spread / Average Target 11,7%
EPS Revisions
Managers and Directors
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Technology Officer
Christoph Franz Chairman
Urs Jaisli Chief Compliance Officer
AndrÚ S. Hoffmann Vice Chairman
Sector and Competitors
1st jan.Capi. (M$)
ROCHE HOLDING AG10.05%322 644
JOHNSON & JOHNSON4.16%431 543
PFIZER, INC.19.32%246 414
NOVO NORDISK A/S50.62%232 291
ELI LILLY AND COMPANY35.22%206 972
ABBVIE INC.-0.69%188 045